EIP
Monika Rai is an accomplished professional in the life sciences sector, currently serving as Partner and Head of Life Sciences at EIP since April 2020. Prior to this role, Monika held the position of Partner at Mathys & Squire LLP from July 2014 to March 2020, and previously worked as a Consultant at GlaxoSmithKline from October 2012 to September 2013. Monika's legal career began at Olswang as a European Patent Attorney from August 2008 to September 2012, following a role as a Technical Assistant at Kilburn & Strode between January 2007 and July 2008. Monika's foundation in law was established with an LLB from the University of Delhi (1999-2002), followed by an LLM in Intellectual Property from The London School of Economics and Political Science (2002-2003), complemented by a BSc (Hons.) in Botany, Zoology, and Chemistry from the University of Delhi (1996-1999). Monika's early legal experience includes serving as an Advocate at Groser & Groser in India from January 2004 to August 2006.
This person is not in any teams
EIP
We specialise in high-value and complex patent matters. Our multidisciplinary team combines patent attorneys, litigators and commercial IP lawyers in three of the world’s main patent markets - Germany, UK and USA and now also in the Nordics through our recent expansion into Sweden. Our patent drafting, prosecution and challenges practice obtains and defends high-value and complex patents for clients, and invalidates patents held by others during post-grant proceedings including oppositions at the European Patent Office (EPO). EIP’s litigation practice has built a strong reputation for quality and success amongst its competitors and clients, with a strong track record including success in a landmark ruling on Standard Essential Patents (SEPs) from the UK Supreme Court. Increasingly our patent attorneys work closely with the litigation team in the UK and Germany providing additional technical expertise on large scale international patent litigation matters. We have represented clients in hundreds of oppositions before the EPO. We counsel clients on strategic patent portfolio development, and have implemented high-level IP strategies for some of the world’s largest companies. We also offer commercial advice on the exploitation and use of the full range of Intellectual Property Rights (IPRs) including patents, trademarks, design rights, copyright and other ancillary issues arising in relation to data protection and rights of privacy.